Ignite Creation Date:
2025-12-24 @ 3:50 PM
Ignite Modification Date:
2026-01-28 @ 8:31 PM
Study NCT ID:
NCT03059992
Status:
COMPLETED
Last Update Posted:
2024-11-20
First Post:
2017-02-14
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment
Sponsor:
Scynexis, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Invasive Candidiasis | View |
| None | Mucocutaneous Candidiasis | View |
| None | Coccidioidomycosis | View |
| None | Histoplasmosis | View |
| None | Blastomycosis | View |
| None | Chronic Pulmonary Aspergillosis | View |
| None | Allergic Bronchopulmonary Aspergillosis | View |
| None | Invasive Pulmonary Aspergillosis | View |
| None | Recurrent Vulvovaginal Candidiasis | View |
| None | Other Emerging Fungi | View |
Keywords: